(Q35568064)

8 August 2017

1 reference

title

Pharmacogenetics of paraoxonases: a brief review (English)

1 reference

genetic predisposition to disease

8 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579013

25 March 2024

genetic polymorphism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579013

25 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00210-003-0833-1

25 March 2024

author name string

D. I. Draganov

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579013

25 March 2024

B. N. La Du

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579013

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14579013

25 March 2024

publication date

25 October 2003

1 reference

full work available at URL

8 August 2017

http://deepblue.lib.umich.edu/bitstream/2027.42/46312/1/210_2003_Article_833.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579013

http://link.springer.com/content/pdf/10.1007/s00210-003-0833-1.pdf

25 March 2024

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00210-003-0833-1

http://link.springer.com/article/10.1007/s00210-003-0833-1/fulltext.html

25 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00210-003-0833-1

http://link.springer.com/content/pdf/10.1007/s00210-003-0833-1

25 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00210-003-0833-1

Naunyn-Schmiedeberg's Archives of Pharmacology

25 March 2024

published in

1 reference

8 August 2017

369

1 reference

8 August 2017

78-88

1 reference

8 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00210-003-0833-1

8 August 2017

0 references

cites work

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

1 reference

12 December 2020

Future studies of low-activity PON1 phenotype subjects may reveal how PON1 protects against cardiovascular disease

1 reference

12 December 2020

Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population.

1 reference

12 December 2020

Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity

1 reference

12 December 2020

Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase

1 reference

12 December 2020

Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera

1 reference

12 December 2020

Paraoxonase genes and disease

1 reference

12 December 2020

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

1 reference

12 December 2020

Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination

1 reference

12 December 2020

'A'-esterases. Enzymes looking for a role?

1 reference

12 December 2020

The genetic mapping and gene structure of mouse paraoxonase/arylesterase.

1 reference

12 December 2020

Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters

1 reference

12 December 2020

Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

1 reference

12 December 2020

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

1 reference

12 December 2020

PON1 status and neurologic symptom complexes in Gulf War veterans

1 reference

12 December 2020

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

1 reference

12 December 2020

Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent

1 reference

12 December 2020

Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese

1 reference

12 December 2020

Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities

1 reference

12 December 2020

Paraoxonase and atherosclerosis

1 reference

12 December 2020

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

1 reference

12 December 2020

Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation

1 reference

12 December 2020

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

1 reference

12 December 2020

Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3.

1 reference

12 December 2020

Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

1 reference

12 December 2020

Genetic polymorphism and interethnic variability of plasma paroxonase activity

1 reference

12 December 2020

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

12 December 2020

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

12 December 2020

A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression

1 reference

12 December 2020

Determination of paraoxonase (PON1) status requires more than genotyping.

1 reference

12 December 2020

Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase

1 reference

12 December 2020

Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls

1 reference

12 December 2020

Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties

1 reference

12 December 2020

Calcium binding by human and rabbit serum paraoxonases. Structural stability and enzymatic activity

1 reference

12 December 2020

Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R

1 reference

12 December 2020

The human serum paraoxonase/arylesterase polymorphism.

1 reference

12 December 2020

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

1 reference

12 December 2020

Does paraoxonase play a role in susceptibility to cardiovascular disease?

1 reference

12 December 2020

1 reference

12 December 2020

Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence

1 reference

12 December 2020

Plasma lipoprotein-associated arylesterase is induced by bacterial lipopolysaccharide

1 reference

12 December 2020

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease

1 reference

12 December 2020

Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation

1 reference

12 December 2020

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism

1 reference

12 December 2020

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

12 December 2020

Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease.

1 reference

12 December 2020

Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor

1 reference

12 December 2020

Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.

1 reference

12 December 2020

An enzyme in animal tissues capable of hydrolysing the phosphorus-fluorine bond of alkyl fluorophosphates

1 reference

12 December 2020

Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes

1 reference

12 December 2020

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

12 December 2020

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

1 reference

12 December 2020

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.

1 reference

12 December 2020

Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress

1 reference

12 December 2020

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

12 December 2020

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

1 reference

12 December 2020

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

1 reference

12 December 2020

Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism

1 reference

12 December 2020

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

1 reference

12 December 2020

Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population

1 reference

12 December 2020

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

1 reference

12 December 2020

Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.

1 reference

12 December 2020

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

1 reference

12 December 2020

Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells

1 reference

12 December 2020

Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease

1 reference

12 December 2020

Polymorphisms in the human paraoxonase (PON1) promoter

1 reference

12 December 2020

Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans.

1 reference

12 December 2020

Molecular variant of the human paraoxonase/arylesterase gene is associated with central retinal vein occlusion in the Japanese population

1 reference

12 December 2020

Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.

1 reference

12 December 2020

A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.

1 reference

12 December 2020

Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease

1 reference

12 December 2020

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

1 reference

12 December 2020

On the physiological role(s) of the paraoxonases

1 reference

12 December 2020

Isolation and complete covalent structure of liver microsomal paraoxonase

1 reference

12 December 2020

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

1 reference

12 December 2020

Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.

1 reference

12 December 2020

Comparison of purified human and rabbit serum paraoxonases

1 reference

12 December 2020

Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals

1 reference

12 December 2020

Identifiers

DOI

1 reference

8 August 2017

1 reference